When combined with an already FDA-approved chemotherapy, a novel agent appears to halt the ability of Ewing sarcoma to grow and progress.
When combined with an already FDA-approved chemotherapy, a novel agent appears to halt the ability of Ewing sarcoma to grow and progress.